000 01472 a2200385 4500
005 20250517122733.0
264 0 _c20171023
008 201710s 0 0 eng d
022 _a1648-9144
024 7 _a10.1016/j.medici.2016.10.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaius, Ott
245 0 0 _aUse of drugs against osteoporosis in the Baltic countries during 2010-2014.
_h[electronic resource]
260 _bMedicina (Kaunas, Lithuania)
_c2016
300 _a315-320 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlendronate
_xadministration & dosage
650 0 4 _aBaltic States
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aCalcium Channel Blockers
_xadministration & dosage
650 0 4 _aDenosumab
_xadministration & dosage
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aDrug Utilization
_xstatistics & numerical data
650 0 4 _aErgocalciferols
_xadministration & dosage
650 0 4 _aFractures, Bone
_xprevention & control
650 0 4 _aHumans
650 0 4 _aIbandronic Acid
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aRisedronic Acid
_xadministration & dosage
700 1 _aMaasalu, Katre
700 1 _aKõks, Sulev
700 1 _aMärtson, Aare
773 0 _tMedicina (Kaunas, Lithuania)
_gvol. 52
_gno. 5
_gp. 315-320
856 4 0 _uhttps://doi.org/10.1016/j.medici.2016.10.001
_zAvailable from publisher's website
999 _c26556447
_d26556447